In the BioHarmony Drug Report Database
Enfuvirtide
Fuzeon (enfuvirtide) is a protein pharmaceutical. Enfuvirtide was first approved as Fuzeon on 2003-03-13. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections.
Trade Name
|
Fuzeon |
|---|---|
Common Name
|
enfuvirtide |
ChEMBL ID
|
CHEMBL525076 |
Indication
|
acquired immunodeficiency syndrome, hiv infections |
Drug Class
|
Peptides: antiviral peptides; antivirals |
Image (chem structure or protein)